Breaking News: Oregon Legalizes Psilocybin Therapy
This article explains Oregon’s Measure 109 and how the state became the first in the U.S. to legalize psilocybin therapy. It covers the approved regulatory process, the role of the Oregon Health Authority, and what the new program could mean for adults 21 and older.
Provider
Details
Enrollment
Course Overview
This course page presents a news-based overview of Oregon’s decision to legalize psilocybin therapy through Measure 109. It explains that voters approved the Oregon Health Authority to establish a psilocybin therapy program and describes the basic scope of the policy change. The material focuses on the evolving regulatory framework, including the two-year rulemaking period and the role of the Oregon Psilocybin Advisory Board. It also notes that licensed facilitators may eventually be able to provide psilocybin to adults 21 or older under state supervision. This content is suited to readers seeking a clear, factual summary of psychedelic policy developments, especially those interested in psilocybin regulation, therapeutic access, and the early structure of Oregon’s program.
Who is this for?
Readers interested in psychedelic policy, psilocybin therapy, and Oregon’s regulatory developments.
About the Provider
Psychedelic media publication covering education, culture, policy, and practical guidance around psychedelic use and integration.
View Double Blind profileCourse Details
- PricePrice on request
- Lifecycle statusNo New Dates
- SkillsIntegrationPsilocybin TherapyMDMA-Assisted TherapyUnderstanding psilocybin policyInterpreting ballot measure outcomesReading regulatory developmentsIdentifying therapeutic use contextsTracking psychedelic industry news